Send to

Choose Destination
J Am Coll Nutr. 1993 Oct;12(5):501-4.

Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report.

Author information

Kenneth L. Jordan Heart Fund, Montclair, New Jersey 07040.


The effect on serum lipids of a flax seed supplement consisting of three slices of flax seed-containing bread and 15 g of ground flax seed was studied in 15 hyperlipemic subjects on long-term intake (800 IU/day) of vitamin E. The flax seed, which was high in alpha-linolenic acid and fiber, and which has been reported to lower serum cholesterol in elderly subjects, was provided in a 3-month feeding trial. Serum total and low-density lipoprotein cholesterol levels were reduced significantly; high-density lipoprotein cholesterol did not change during flax seed consumption. Thrombin-stimulated platelet aggregation decreased with the supplement. Serum lipid oxidation products decreased significantly during the washout period.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center